Insider Transactions in Q2 2022 at Cerevel Therapeutics Holdings, Inc. (CERE)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Gabrielle Sulzberger |
BUY
Exercise of conversion of derivative security
|
Direct |
14,270
+18.26%
|
-
|
|
Apr 13
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
45,000
-95.79%
|
$1,530,000
$34.65 P/Share
|
|
Apr 13
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+48.92%
|
$135,000
$3.5 P/Share
|